▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
p 13.15625
ain 0.91259765625
▁and 0.9853515625
▁dem 8.4609375
oral 3.57421875
ization 0.288818359375
. 1.5107421875
▁Chron 6.3125
ic 0.034149169921875
▁pain 0.39892578125
▁is 1.2998046875
▁always 6.36328125
▁accompanied 2.650390625
▁by 0.07257080078125
▁negative 4.8203125
▁emot 1.525390625
ional 1.3955078125
▁experiences 2.9921875
▁and 2.15625
▁blocks 10.9765625
▁a 4.125
▁person 1.5693359375
’ 23.8125
s 2.75
▁ability 1.966796875
▁to 0.050811767578125
▁receive 6.1875
▁joy 5.06640625
▁and 1.3955078125
▁satisfaction 3.02734375
▁fro 12.3828125
▁m 2.0234375
▁life 1.3896484375
. 0.361572265625
▁The 1.99609375
▁research 3.984375
▁investig 5.54296875
ates 0.43701171875
▁the 0.4931640625
▁development 6.125
▁of 0.2076416015625
▁de 4.0234375
pression 0.198974609375
▁and 1.244140625
▁anx 2.451171875
iety 0.0113983154296875
▁among 2.35546875
▁patients 2.62109375
▁receiving 4.3515625
▁ph 6.6640625
arma 2.01953125
ce 0.0236053466796875
ut 0.007080078125
ical 0.0154876708984375
▁op 4.82421875
io 0.171142578125
ids 0.66357421875
▁and 2.330078125
▁medical 6.15625
▁mar 1.2578125
iju 0.057098388671875
ana 0.001392364501953125
▁( 4.63671875
MM 0.8974609375
) 3.146484375
▁as 2.8515625
▁severe 10.09375
▁pain 1.7841796875
kill 3.26953125
ers 0.00679779052734375
. 0.5439453125
▁It 3.255859375
▁comp 5.125
ares 0.056793212890625
▁the 0.63427734375
▁effic 6.3984375
acy 0.0163421630859375
▁of 0.285888671875
▁pres 5.04296875
cri 2.03515625
ptions 0.8359375
▁and 2.328125
▁exam 6.0546875
ines 0.01287078857421875
▁the 0.4443359375
▁possibility 3.87109375
▁of 0.1002197265625
▁post 7.125
- 0.88818359375
tre 2.51171875
at 0.02252197265625
ment 0.0197601318359375
▁de 1.8701171875
pression 0.0947265625
. 1.7734375
<0x0A> 2.388671875
There 4.83203125
▁is 1.0654296875
▁currently 4.59765625
▁a 1.1484375
▁severe 5.015625
▁lack 3.08984375
▁of 0.0283050537109375
▁information 2.146484375
▁about 1.439453125
▁the 0.495849609375
▁effects 2.923828125
▁of 0.0799560546875
▁op 1.7841796875
i 3.849609375
ates 0.195068359375
. 3.716796875
▁They 4.984375
▁manage 8.828125
▁pain 3.341796875
▁successfully 5.84375
, 1.0927734375
▁but 0.3447265625
▁the 2.60546875
▁past 9.390625
▁few 2.48046875
▁dec 0.86865234375
ades 0.0003070831298828125
▁indicated 9.7734375
▁the 2.109375
▁growing 4.72265625
▁concern 3.580078125
▁regarding 2.9375
▁op 3.48828125
iate 0.66748046875
▁ab 1.5029296875
use 0.00890350341796875
▁in 3.419921875
▁forms 10.5546875
▁of 0.407470703125
▁over 3.3671875
d 0.38916015625
ose 0.1953125
▁and 0.716796875
▁add 1.1005859375
iction 0.0279541015625
. 0.206298828125
▁A 4.01953125
▁more 5.6875
▁manage 8.9921875
able 0.00580596923828125
▁and 2.26171875
▁sa 2.41015625
fer 0.00024271011352539062
▁alternative 1.689453125
▁might 6.3828125
▁be 0.1900634765625
▁medical 2.75390625
▁mar 0.167724609375
iju 0.00726318359375
ana 0.0014495849609375
. 1.5185546875
▁However 2.8515625
, 0.0100555419921875
▁the 1.6015625
▁legal 4.13671875
▁status 1.236328125
▁and 2.798828125
▁novel 9.3984375
ty 0.70849609375
▁of 0.196533203125
▁this 1.62890625
▁drug 2.0859375
▁do 5.04296875
▁not 0.07513427734375
▁allow 1.07421875
▁finding 8.859375
▁a 2.3046875
▁large 4.39453125
▁number 1.4208984375
▁of 0.00609588623046875
▁studies 1.37109375
▁on 1.537109375
▁its 0.990234375
▁effect 2.0390625
iveness 0.427001953125
. 0.97314453125
▁Specifically 8.359375
, 0.11883544921875
▁it 2.70703125
▁concerns 4.8671875
▁the 0.6376953125
▁emot 7.26171875
ional 0.017303466796875
▁condition 5.37890625
▁of 0.359130859375
▁patients 0.72607421875
▁experien 6.20703125
cing 0.00024509429931640625
▁chron 1.224609375
ic 0.0024204254150390625
▁pain 0.10614013671875
. 0.7021484375
▁This 3.173828125
▁research 2.9453125
▁paper 6.23046875
▁a 2.15625
ims 0.0005741119384765625
▁to 0.09881591796875
▁analyze 3.052734375
▁levels 9.6171875
▁of 0.033935546875
▁de 0.591796875
pression 0.033966064453125
▁and 0.2548828125
▁anx 0.048980712890625
iety 0.002048492431640625
▁among 0.7607421875
people 11.328125
▁receiving 0.7294921875
▁ther 7.92578125
apy 0.357421875
by 9.546875
▁comparing 7.71484375
▁the 1.0634765625
▁effects 2.1953125
▁of 0.043304443359375
▁ph 2.361328125
arma 0.0662841796875
ce 0.002216339111328125
ut 0.0005421638488769531
ical 0.004486083984375
▁op 0.2080078125
io 0.1285400390625
ids 0.053009033203125
▁and 0.366943359375
▁MM 1.943359375
. 1.0986328125
<0x0A> 1.091796875
The 1.384765625
▁study 2.189453125
▁was 2.236328125
▁conducted 0.77197265625
▁in 1.5458984375
▁the 1.47265625
▁form 2.2265625
▁of 0.01873779296875
▁collection 10.046875
▁and 1.69140625
▁analysis 0.6611328125
▁of 0.051513671875
▁statistical 4.15234375
▁data 0.1253662109375
. 0.93603515625
▁Part 4.94140625
icip 0.07708740234375
ants 0.05218505859375
▁w 9.8671875
▁ere 1.5927734375
▁rec 2.68359375
ru 0.004505157470703125
ited 0.0012140274047851562
▁for 4.1171875
▁six 7.5234375
▁months 0.56201171875
▁at 3.720703125
▁two 2.486328125
▁major 5.3828125
▁pain 3.041015625
▁relief 5.5078125
▁cent 1.4892578125
ers 0.0902099609375
▁in 0.68115234375
▁Israel 4.64453125
. 0.452392578125
▁The 1.1904296875
▁research 2.154296875
ers 1.6142578125
▁used 2.646484375
▁The 7.72265625
▁De 4.23046875
pression 0.015777587890625
▁Module 9.9375
▁of 1.0107421875
▁the 0.349853515625
▁Pat 2.337890625
ient 0.0089874267578125
▁ 10.171875
▁Health 7.2890625
▁Question 0.34814453125
naire 0.042266845703125
▁and 3.330078125
▁the 0.76171875
▁General 1.806640625
ized 0.75634765625
▁An 0.0219879150390625
x 0.0004353523254394531
iety 0.004451751708984375
▁Dis 0.5439453125
order 0.04388427734375
▁Sc 1.3056640625
ale 0.08282470703125
▁to 1.7626953125
▁interview 7.09765625
▁participants 1.880859375
, 3.583984375
▁evaluate 5.671875
▁their 0.7626953125
▁answers 6.65625
, 0.8916015625
▁and 0.1663818359375
▁conduct 4.5
▁the 2.212890625
▁study 2.3671875
. 0.2210693359375
▁To 5.3125
▁specifically 10.0
▁evaluate 2.583984375
▁and 4.26171875
▁compare 1.03515625
▁the 0.339111328125
▁prob 11.1171875
abilities 0.1409912109375
▁of 0.1376953125
▁de 0.97900390625
pression 0.036651611328125
▁or 4.40625
▁anx 0.047698974609375
iety 0.0012731552124023438
▁among 1.767578125
▁the 2.2890625
▁diverse 8.7578125
▁groups 1.6611328125
, 1.48828125
▁the 1.0458984375
▁study 2.814453125
▁used 1.6396484375
▁multiple 4.640625
▁log 2.83203125
istic 0.0413818359375
▁regression 0.118408203125
▁analysis 0.66162109375
▁and 2.58203125
▁chose 8.9296875
▁medical 7.5703125
▁mar 0.334716796875
iju 0.006267547607421875
ana 0.0027217864990234375
▁as 0.7939453125
▁the 1.0625
▁control 2.7265625
▁group 0.60302734375
. 0.29296875
<0x0A> 0.796875
This 3.44140625
▁type 5.8515625
▁of 0.00977325439453125
▁study 1.806640625
▁is 1.236328125
▁the 3.412109375
▁most 1.69921875
▁reve 9.140625
aling 0.0013780593872070312
▁and 1.029296875
in 10.328125
clus 4.18359375
ive 0.006092071533203125
, 2.48046875
▁as 1.9931640625
▁it 0.337890625
▁contains 5.09375
direct 11.5234375
▁responses 5.84765625
▁from 0.82275390625
▁a 3.73828125
▁large 0.970703125
▁number 0.441650390625
▁of 0.026824951171875
▁participants 1.396484375
. 0.736328125
▁All 4.78125
▁tool 13.5390625
▁s 5.02734375
▁in 4.84375
▁the 0.6884765625
▁form 4.01953125
▁of 0.04852294921875
▁question 1.7470703125
na 0.03857421875
ires 0.001987457275390625
▁and 2.140625
▁scales 3.705078125
▁have 3.947265625
▁already 4.87890625
▁been 0.142578125
▁used 2.091796875
▁and 2.373046875
▁ 8.71875
▁proved 7.14453125
▁their 1.5751953125
▁effic 3.595703125
acy 0.0009927749633789062
▁for 3.322265625
▁collect 4.8203125
ing 0.0158233642578125
▁analyt 8.21875
ical 0.243408203125
▁data 0.28759765625
. 0.52587890625
▁It 3.517578125
▁helps 4.91796875
▁to 0.9111328125
▁system 7.4765625
at 1.015625
ize 0.026275634765625
▁and 1.7060546875
▁class 4.15625
ify 0.0077972412109375
▁distinct 9.34375
▁kinds 5.86328125
▁of 0.0254058837890625
▁information 3.486328125
▁for 4.06640625
▁subsequent 4.32421875
▁un 8.2421875
comp 5.578125
licated 0.0687255859375
▁services 11.8515625
. 0.72509765625
▁Thus 4.51171875
, 0.0355224609375
▁research 4.6640625
ers 0.69580078125
▁can 1.30078125
▁compare 4.265625
▁the 1.0556640625
▁effects 3.052734375
▁of 0.097900390625
▁medic 4.30859375
ations 0.841796875
▁on 1.9072265625
▁patients 2.083984375
▁of 4.5390625
▁diverse 3.953125
▁age 2.619140625
▁groups 0.6103515625
, 0.935546875
▁background 4.87109375
s 0.23486328125
, 0.09503173828125
▁physical 5.203125
▁conditions 1.34375
, 0.11187744140625
▁emot 5.55859375
ional 0.06463623046875
▁states 1.3330078125
, 0.1275634765625
▁and 0.462890625
▁so 3.318359375
▁on 0.294921875
. 0.10833740234375
<0x0A> 0.80859375
The 1.18359375
▁analysis 4.62890625
▁of 0.54736328125
▁any 8.4921875
▁human 6.38671875
▁reaction 4.78125
▁has 4.46484375
▁a 1.912109375
▁high 4.53515625
▁potential 3.38671875
▁of 1.607421875
▁subject 5.875
iveness 3.76953125
▁and 1.439453125
▁bias 2.609375
, 1.8056640625
▁especially 2.669921875
▁regarding 4.421875
▁people 4.78515625
▁in 3.859375
▁severe 4.578125
▁pain 0.31640625
▁and 2.640625
▁un 5.47265625
stable 1.810546875
▁emot 0.96044921875
ional 0.167724609375
▁condition 2.478515625
. 0.0919189453125
▁Perhaps 8.859375
▁some 5.0625
▁patients 2.376953125
▁tend 5.6484375
▁to 0.0308837890625
ex 7.96875
agger 0.0124969482421875
ate 0.022186279296875
▁their 0.94921875
▁de 4.99609375
press 1.8720703125
ive 0.4111328125
▁state 2.96484375
▁or 1.8955078125
▁vice 8.15625
▁vers 0.024078369140625
a 0.0035495758056640625
, 1.158203125
▁de 7.80859375
- 3.912109375
emph 0.98583984375
as 0.00867462158203125
ize 0.128173828125
▁serious 6.609375
▁difficulties 5.9453125
. 0.99267578125
▁Because 6.0859375
▁the 2.296875
▁survey 5.91796875
▁responses 6.5
▁were 1.5986328125
▁thoroughly 8.359375
▁anonymous 4.890625
, 0.4541015625
▁the 1.49609375
▁research 1.498046875
ers 0.260498046875
▁were 1.423828125
▁unable 2.36328125
▁to 0.061279296875
▁carefully 8.6953125
▁analyze 1.6298828125
▁each 3.841796875
▁patient 2.748046875
’ 25.515625
s 0.56787109375
▁reaction 3.478515625
▁and 2.455078125
▁compare 3.6328125
▁it 0.841796875
▁to 1.26171875
▁the 0.7861328125
▁actual 5.453125
▁states 7.25390625
▁of 0.6376953125
▁condition 7.2265625
. 0.4033203125
▁More 6.890625
▁accurate 4.1875
▁answers 4.765625
▁could 2.41796875
▁be 0.9013671875
▁obtained 0.9609375
▁by 1.3828125
▁professional 7.50390625
▁psych 2.220703125
olog 0.337158203125
ists 0.0047760009765625
▁via 7.78125
▁personal 3.93359375
▁communication 4.76171875
▁and 1.931640625
▁behavior 7.390625
al 0.3095703125
▁analysis 2.375
. 0.25732421875
▁However 2.634765625
, 0.004665374755859375
▁this 2.05859375
▁method 2.802734375
▁of 2.177734375
▁research 2.197265625
▁is 0.94775390625
▁way 7.98046875
▁more 1.4697265625
▁resource 6.58984375
- 0.470703125
int 0.55078125
ensive 0.00934600830078125
▁and 0.66650390625
▁energy 8.8828125
- 0.1644287109375
consum 0.309814453125
ing 0.00353240966796875
. 0.66943359375
<0x0A> 0.70849609375
Part 5.60546875
icip 0.07843017578125
ants 0.133544921875
▁were 1.0
▁rec 1.71484375
ru 0.0017824172973632812
ited 0.0003871917724609375
▁for 1.2099609375
▁six 1.16796875
▁months 0.07855224609375
▁at 0.455078125
▁two 0.1258544921875
▁major 0.267333984375
▁pain 0.053314208984375
▁relief 0.0255889892578125
▁cent 0.022857666015625
ers 0.011138916015625
▁in 0.06195068359375
▁Israel 0.052215576171875
. 0.13525390625
▁All 3.6640625
▁patients 1.7236328125
▁experienced 5.67578125
▁chron 1.9287109375
ic 0.00299072265625
▁pain 0.1319580078125
▁for 3.271484375
▁at 0.7587890625
▁least 0.004428863525390625
▁ 1.0322265625
3 1.3564453125
▁months 0.210205078125
. 1.029296875
▁The 1.44921875
▁study 2.017578125
▁included 2.17578125
▁ 1.166015625
8 2.76953125
9 2.822265625
0 3.822265625
▁participants 1.546875
, 1.2548828125
▁of 1.8251953125
▁which 0.4814453125
▁ 0.169677734375
4 1.6162109375
7 2.46875
4 2.775390625
▁( 2.2890625
5 0.12353515625
9 11.078125
%) 0.94970703125
▁were 0.5595703125
▁treated 4.70703125
▁sole 6.80078125
ly 0.00027179718017578125
▁with 0.335693359375
▁op 0.865234375
io 0.413330078125
ids 0.1790771484375
, 1.1416015625
▁ 0.65673828125
3 1.1044921875
2 2.12109375
9 2.55859375
▁( 0.07489013671875
4 1.2568359375
1 1.263671875
%) 0.1348876953125
▁were 1.408203125
▁tre 6.62109375
a 3.228515625
▁ted 0.5791015625
▁with 0.26513671875
▁MM 0.64501953125
, 0.1619873046875
▁and 0.147705078125
▁ 0.1746826171875
7 3.029296875
7 2.4453125
▁( 0.2125244140625
8 3.84765625
. 1.0615234375
6 2.880859375
%) 0.0570068359375
▁acquired 9.546875
▁both 1.0869140625
▁( 6.890625
Fe 10.1015625
ing 2.77734375
old 0.0235137939453125
▁et 1.4248046875
▁al 0.03350830078125
., 0.3720703125
▁ 0.057891845703125
2 0.1806640625
0 0.0018138885498046875
1 0.4501953125
7 2.21484375
). 0.146240234375
▁The 1.302734375
▁remaining 6.65234375
▁ten 8.3828125
▁participants 1.345703125
▁who 5.19921875
▁did 1.40234375
▁not 0.021026611328125
▁receive 1.84375
▁ph 3.060546875
arma 0.07403564453125
ce 0.0031452178955078125
ut 0.0011911392211914062
ical 0.003528594970703125
▁op 0.84326171875
io 0.09417724609375
ids 0.024139404296875
▁and 1.779296875
▁medical 2.166015625
▁mar 0.05517578125
iju 0.01422882080078125
ana 0.0010833740234375
▁were 1.2958984375
▁with 5.9921875
dra 0.2198486328125
wn 0.0006947517395019531
▁from 0.254638671875
▁the 0.1231689453125
▁analysis 4.6875
▁in 4.875
▁the 1.263671875
▁research 4.28515625
. 0.7041015625
▁Therefore 4.9140625
, 0.01029205322265625
▁it 3.76953125
▁is 0.8798828125
▁not 2.638671875
▁possible 0.7919921875
▁to 0.04864501953125
▁compreh 6.45703125
ens 0.050689697265625
ively 0.017578125
▁compare 2.1328125
▁patients 4.6953125
▁taking 4.171875
▁medic 3.744140625
ations 0.431396484375
▁with 0.93505859375
▁those 1.2021484375
▁who 1.1748046875
▁do 1.72265625
▁not 0.0139007568359375
. 0.76171875
<0x0A> 0.66015625
The 1.1396484375
▁study 1.7958984375
▁conducted 4.890625
▁a 2.587890625
▁correlation 5.97265625
▁type 7.4296875
▁of 0.447509765625
▁research 1.8828125
▁with 2.869140625
▁variable 8.1015625
▁measures 4.50390625
. 1.2646484375
▁It 2.169921875
▁evaluated 4.4609375
▁the 0.59130859375
▁inter 6.18359375
dep 3.720703125
end 0.002674102783203125
ence 0.0150299072265625
▁of 0.57470703125
▁various 3.90234375
▁factors 1.7021484375
▁that 2.796875
▁affected 4.1015625
▁the 0.61474609375
▁physical 6.80078125
▁and 0.91943359375
▁emot 0.517578125
ional 0.0005192756652832031
▁condition 1.0693359375
▁of 0.1097412109375
▁patients 0.5810546875
▁experien 4.12109375
cing 0.0003952980041503906
▁chron 0.5703125
ic 0.0007500648498535156
▁pain 0.032867431640625
. 0.221435546875
▁For 3.927734375
▁example 1.3017578125
, 0.015472412109375
▁the 1.212890625
▁survey 5.078125
▁showed 3.185546875
▁that 0.403076171875
▁the 1.7294921875
▁ratio 6.96484375
▁of 0.1444091796875
▁female 4.44921875
▁patients 0.810546875
▁was 1.90234375
▁remark 9.4140625
ably 0.0026569366455078125
▁higher 0.53759765625
▁in 2.7265625
▁the 0.888671875
▁op 4.5625
i 3.69921875
ates 0.250732421875
▁group 0.31298828125
▁compared 2.7421875
▁to 0.1512451171875
▁the 0.46142578125
▁MM 0.6162109375
▁group 0.28466796875
. 0.50439453125
▁In 2.982421875
▁turn 3.9765625
, 0.004985809326171875
▁people 6.2109375
▁on 5.4765625
▁op 1.4912109375
i 0.463623046875
ates 0.007678985595703125
▁were 1.09375
▁more 0.98876953125
▁likely 0.35498046875
▁to 0.07696533203125
▁report 2.978515625
▁major 5.921875
▁de 0.42138671875
press 1.3193359375
ive 0.005733489990234375
▁dis 0.5029296875
orders 1.552734375
. 1.8310546875
<0x0A> 2.306640625
The 1.0810546875
question 12.109375
na 1.2216796875
ires 0.006671905517578125
▁used 2.177734375
▁different 8.2265625
▁variable 8.1171875
▁measures 1.03125
▁to 1.3525390625
▁collect 2.2890625
▁information 1.955078125
. 1.501953125
▁For 2.248046875
▁example 0.267333984375
, 0.00969696044921875
▁it 3.931640625
▁included 2.412109375
▁compreh 8.6953125
ensive 0.02886962890625
▁so 6.9140625
cio 0.08270263671875
- 0.479736328125
dem 0.09967041015625
ographic 0.0389404296875
▁data 1.1044921875
: 4.92578125
▁gender 1.5966796875
, 0.09710693359375
▁age 0.209228515625
, 0.09429931640625
▁country 4.51171875
, 1.60546875
▁type 4.25
▁of 0.05291748046875
▁residence 3.8671875
▁( 3.353515625
urban 2.072265625
/ 2.9296875
r 0.074462890625
ural 0.0022678375244140625
), 0.2264404296875
▁years 5.91015625
▁of 0.1854248046875
▁education 0.78662109375
, 0.14697265625
▁and 1.796875
▁employ 3.70703125
ment 0.0059661865234375
▁status 0.4326171875
. 0.1845703125
▁Pat 4.25
ients 0.10638427734375
▁were 1.140625
also 7.03125
▁asked 0.90625
▁about 1.6083984375
▁their 0.7578125
▁medical 2.990234375
▁history 0.474365234375
▁over 8.3828125
▁the 0.1806640625
▁years 3.65234375
▁and 1.7626953125
▁the 1.865234375
▁current 3.705078125
▁presence 5.8984375
▁of 0.063720703125
▁any 2.5625
▁severe 4.69921875
▁dise 1.49609375
ases 0.0008883476257324219
▁such 3.962890625
▁as 0.032501220703125
▁heart 2.255859375
▁failure 2.013671875
, 0.1875
▁di 1.884765625
ab 0.002933502197265625
etes 0.006092071533203125
, 0.1444091796875
▁ar 3.68359375
th 0.1644287109375
rit 0.036529541015625
is 0.01287841796875
, 0.051361083984375
▁and 1.646484375
▁so 0.88134765625
▁on 0.039337158203125
. 0.049713134765625
▁The 1.787109375
▁third 7.05859375
▁measure 4.05078125
▁of 1.978515625
▁the 0.9765625
▁question 2.34765625
naire 0.292724609375
▁was 1.048828125
▁indicated 9.4609375
▁by 0.767578125
▁information 6.70703125
▁on 1.5712890625
▁any 5.37890625
▁twelve 13.3984375
- 1.373046875
month 0.392822265625
▁and 5.8515625
▁lifetime 3.13671875
▁drug 4.6484375
▁and 3.564453125
▁alco 0.0821533203125
hol 0.0003871917724609375
▁consumption 2.646484375
. 0.473876953125
▁In 3.46484375
add 9.71875
ition 0.039947509765625
, 0.2227783203125
▁the 1.255859375
▁record 7.921875
▁included 1.7099609375
▁a 2.439453125
▁pain 6.3671875
▁measurement 4.28515625
▁scale 0.94189453125
▁from 3.60546875
▁ 0.414306640625
0 0.5419921875
▁to 0.4208984375
▁ 0.0293121337890625
1 0.08740234375
0 0.0684814453125
▁to 4.53125
▁evaluate 1.4521484375
▁dis 6.05078125
com 0.1605224609375
fort 0.0027446746826171875
▁feelings 7.2421875
▁during 3.263671875
▁the 0.9150390625
▁last 1.4169921875
▁month 1.611328125
. 0.282958984375
<0x0A> 1.1484375
Am 7.03515625
ong 0.01499176025390625
▁all 2.447265625
▁participants 2.03125
▁in 3.87109375
▁the 0.1851806640625
▁study 0.44580078125
, 0.0706787109375
▁ 0.71728515625
4 1.6669921875
2 2.76953125
. 1.8193359375
2 2.296875
% 0.1505126953125
▁suffered 5.0078125
▁from 0.156494140625
▁de 2.01953125
pression 0.1552734375
, 1.1396484375
▁and 1.7548828125
▁ 0.1837158203125
3 1.7255859375
7 2.25
% 2.666015625
▁ex 9.953125
pe 2.064453125
▁rien 2.734375
ced 0.7998046875
▁excess 7.48046875
ive 0.08056640625
▁anx 0.34619140625
iety 0.0062255859375
. 0.367431640625
▁The 1.3740234375
▁pl 11.015625
ur 0.89501953125
ality 0.001399993896484375
▁of 0.2138671875
▁de 3.57421875
press 1.4677734375
ive 0.041534423828125
▁dis 1.8515625
orders 0.071533203125
▁among 3.970703125
▁patients 1.0908203125
▁int 9.71875
he 1.0986328125
▁op 1.9921875
i 1.064453125
ates 0.014434814453125
, 6.859375
▁medical 2.37109375
▁mar 0.042022705078125
iju 0.0421142578125
ana 0.001903533935546875
, 0.09423828125
▁and 0.08782958984375
▁mixed 5.4140625
▁OP 8.7109375
MM 5.8515625
▁groups 0.59375
▁number 8.0859375
ed 0.01178741455078125
▁ 0.1611328125
5 2.2421875
7 2.509765625
. 0.221435546875
1 2.369140625
%, 0.25439453125
▁ 0.031494140625
2 2.89453125
2 2.44140625
▁. 10.4921875
3 2.505859375
%, 0.18505859375
▁and 0.0826416015625
▁ 0.03253173828125
5 3.166015625
1 2.60546875
. 0.262451171875
4 2.17578125
%, 0.3798828125
▁respectively 0.057952880859375
. 0.22119140625
▁The 1.4599609375
▁pl 4.625
ur 0.03973388671875
ality 0.00025844573974609375
▁of 0.06732177734375
▁anx 0.77490234375
iety 0.032745361328125
▁contained 11.1953125
▁ 0.68701171875
4 1.625
8 2.400390625
. 0.0714111328125
4 2.30859375
% 0.51123046875
▁among 1.5712890625
▁OP 6.3125
▁patients 8.9765625
, 0.28955078125
▁ 0.1217041015625
2 1.5009765625
1 2.47265625
. 0.248291015625
5 2.263671875
% 0.018524169921875
▁among 0.3876953125
▁MM 0.5380859375
▁patients 0.224609375
, 0.0136566162109375
▁and 0.053955078125
▁ 0.057159423828125
3 1.236328125
8 2.595703125
. 0.144775390625
7 2.2578125
% 0.01983642578125
▁among 0.241455078125
▁OP 4.33984375
MM 0.293701171875
▁participants 3.447265625
. 0.193603515625
▁Pat 5.82421875
ients 0.031158447265625
▁who 2.40625
▁took 2.794921875
▁strong 8.109375
▁op 1.181640625
i 1.462890625
ates 0.008636474609375
▁were 1.8203125
▁t 8.515625
ended 1.1455078125
▁to 0.0275421142578125
▁place 10.484375
▁their 3.7734375
▁pain 2.671875
▁on 3.59765625
▁a 0.779296875
▁scale 2.388671875
▁of 0.67138671875
▁ 0.29345703125
9 2.998046875
▁to 1.1884765625
▁ 0.028228759765625
1 0.025299072265625
0 0.0850830078125
( 7.44921875
Fe 2.396484375
ing 0.0264434814453125
old 0.004528045654296875
▁et 0.037872314453125
▁al 0.0080108642578125
., 0.0181732177734375
▁ 0.019989013671875
2 0.0011816024780273438
0 0.0002970695495605469
1 0.0038471221923828125
7 0.024383544921875
). 0.06317138671875
▁They 4.703125
▁were 1.392578125
▁also 1.4716796875
▁an 8.6640625
gu 4.1796875
ished 0.043853759765625
▁em 8.1796875
otion 0.034454345703125
ally 0.007549285888671875
▁and 1.21875
▁react 6.93359375
ed 0.044586181640625
▁rad 9.5546875
ically 0.0294647216796875
▁neg 5.30078125
atively 0.004474639892578125
▁to 0.400634765625
▁almost 5.37109375
▁all 1.2197265625
▁survey 7.86328125
▁questions 0.5419921875
. 0.268798828125
▁Pat 4.140625
ients 0.01166534423828125
▁who 1.208984375
▁took 1.447265625
▁only 5.6015625
▁MM 1.158203125
▁or 3.16015625
▁mixed 3.435546875
▁medic 2.564453125
ations 0.275390625
▁course 12.5234375
▁had 2.546875
▁a 1.3505859375
▁significantly 2.556640625
▁more 3.99609375
▁stable 3.376953125
▁emot 1.259765625
ional 0.00827789306640625
▁state 0.78857421875
▁and 1.443359375
▁cop 5.63671875
ed 0.9677734375
▁with 0.81005859375
▁pain 1.5322265625
▁more 1.6123046875
▁manage 6.73046875
able 2.4609375
. 0.49951171875
<0x0A> 0.72265625
One 5.234375
▁of 0.65185546875
▁the 0.04193115234375
▁major 2.455078125
▁limitations 2.75390625
▁is 3.9140625
▁the 0.5810546875
▁ins 4.82421875
u 0.0504150390625
fficient 0.15283203125
ly 4.859375
▁high 3.10546875
▁response 2.9765625
▁rate 0.139892578125
, 2.60546875
▁ 4.4296875
5 2.0625
7 2.0390625
% 2.091796875
▁instead 7.45703125
▁of 0.016845703125
▁ 0.7451171875
7 1.544921875
0 1.513671875
% 1.0166015625
▁( 1.8056640625
Fe 0.314453125
ing 0.01062774658203125
old 0.0017156600952148438
▁et 0.00931549072265625
▁al 0.005840301513671875
., 0.0106353759765625
▁ 0.01393890380859375
2 0.0006670951843261719
0 0.0001747608184814453
1 0.0017099380493164062
7 0.0105133056640625
). 0.04473876953125
▁It 2.775390625
▁can 3.26953125
▁be 0.3935546875
▁fairly 8.4296875
▁explained 1.7666015625
▁by 0.2001953125
▁the 0.323486328125
▁weak 8.1484375
▁focus 7.046875
▁of 0.443359375
▁respond 6.421875
ents 0.139892578125
▁who 3.50390625
▁have 4.1484375
▁overcome 8.0390625
▁severe 2.39453125
▁pain 0.50439453125
▁sens 8.625
ations 1.0029296875
▁and 1.2451171875
▁de 4.45703125
press 1.8779296875
ive 0.27685546875
▁episodes 4.15625
. 0.630859375
▁It 3.3671875
▁is 0.8515625
▁not 2.626953125
▁clear 4.23046875
▁how 1.7021484375
to 7.22265625
▁use 5.26953125
▁these 3.09375
▁statistics 3.337890625
, 2.720703125
▁as 1.4072265625
▁they 1.27734375
▁still 6.11328125
▁may 4.66796875
▁be 1.333984375
▁relevant 5.875
▁for 1.337890625
▁the 1.884765625
▁overall 4.65625
▁analysis 3.103515625
. 1.158203125
